bepridil has been researched along with Cardiovascular Diseases in 3 studies
Bepridil: A long-acting calcium-blocking agent with significant anti-anginal activity. The drug produces significant coronary vasodilation and modest peripheral effects. It has antihypertensive and selective anti-arrhythmia activities and acts as a calmodulin antagonist.
bepridil : A tertiary amine in which the substituents on nitrogen are benzyl, phenyl and 3-(2-methylpropoxy)-2-(pyrrolidin-1-yl)propyl.
Cardiovascular Diseases: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.
| Excerpt | Relevance | Reference |
|---|---|---|
| "It is unknown whether bepridil improves cardiovascular events in atrial fibrillation (AF) patients, so this study evaluated the clinical outcome in paroxysmal or persistent AF patients receiving bepridil." | 7.77 | Clinical outcome in patients with paroxysmal or persistent atrial fibrillation receiving bepridil. ( Hagiwara, N; Hosaka, F; Naganuma, M; Shiga, T; Shoda, M; Suzuki, A, 2011) |
| "It is unknown whether bepridil improves cardiovascular events in atrial fibrillation (AF) patients, so this study evaluated the clinical outcome in paroxysmal or persistent AF patients receiving bepridil." | 3.77 | Clinical outcome in patients with paroxysmal or persistent atrial fibrillation receiving bepridil. ( Hagiwara, N; Hosaka, F; Naganuma, M; Shiga, T; Shoda, M; Suzuki, A, 2011) |
| "Bepridil is an effective antianginal drug, but, because of its proarrhythmic potential, it should probably not be used as a first-line agent." | 2.37 | Nicardipine, nitrendipine, and bepridil: new calcium antagonists for cardiovascular disorders. ( Hasegawa, GR, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shiga, T | 1 |
| Suzuki, A | 1 |
| Naganuma, M | 1 |
| Hosaka, F | 1 |
| Shoda, M | 1 |
| Hagiwara, N | 1 |
| J Munasinghe, TC | 1 |
| Seneviratne, CK | 1 |
| Thabrew, MI | 1 |
| Abeysekera, AM | 1 |
| Hasegawa, GR | 1 |
1 review available for bepridil and Cardiovascular Diseases
| Article | Year |
|---|---|
Nicardipine, nitrendipine, and bepridil: new calcium antagonists for cardiovascular disorders.
Topics: Bepridil; Calcium Channel Blockers; Cardiovascular Diseases; Humans; Nicardipine; Nitrendipine; Pyrr | 1988 |
2 other studies available for bepridil and Cardiovascular Diseases
| Article | Year |
|---|---|
Clinical outcome in patients with paroxysmal or persistent atrial fibrillation receiving bepridil.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Bepridil; Cardiovascular Diseases; Dose-Response | 2011 |
Antiradical and antilipoperoxidative effects of some plant extracts used by Sri Lankan traditional medical practitioners for cardioprotection.
Topics: Animals; Antioxidants; Bepridil; Biphenyl Compounds; Cardiotonic Agents; Cardiovascular Diseases; De | 2001 |